Descriptor English: | Prostaglandin D2 | ||||||
Descriptor Spanish: |
Prostaglandina D2
| ||||||
Descriptor Portuguese: | Prostaglandina D2 | ||||||
Descriptor French: | Prostaglandine D2 | ||||||
Entry term(s): |
11 Dehydroprostaglandin F2 alpha 11 Dehydroprostaglandin F2alpha 11-Dehydroprostaglandin F2 alpha 11-Dehydroprostaglandin F2alpha D2, Prostaglandin F2 alpha, 11-Dehydroprostaglandin F2alpha, 11-Dehydroprostaglandin PGD2 alpha, 11-Dehydroprostaglandin F2 |
||||||
Tree number(s): |
D10.251.355.255.550.200.200 D23.469.050.175.725.200.200 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015230 | ||||||
Scope note: | The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Registry Number: | RXY07S6CZ2 | ||||||
CAS Type 1 Name: | Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9alpha,13E,15S)- | ||||||
Previous Indexing: |
Prostaglandins (1966-1977) Prostaglandins D (1978-1988) |
||||||
Public MeSH Note: | 89 |
||||||
History Note: | 89 |
||||||
DeCS ID: | 23804 | ||||||
Unique ID: | D015230 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1989/01/01 | ||||||
Date of Entry: | 1988/05/12 | ||||||
Revision Date: | 2015/06/08 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Prostaglandin D2
- Preferred
Concept UI |
M0023403 |
Scope note | The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. |
Preferred term | Prostaglandin D2 |
Entry term(s) |
11 Dehydroprostaglandin F2 alpha 11 Dehydroprostaglandin F2alpha 11-Dehydroprostaglandin F2 alpha 11-Dehydroprostaglandin F2alpha D2, Prostaglandin F2 alpha, 11-Dehydroprostaglandin F2alpha, 11-Dehydroprostaglandin PGD2 alpha, 11-Dehydroprostaglandin F2 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey